| The Arizona Board of Regents Patent applications |
| Patent application number | Title | Published |
|---|
| 20110305924 | METALLIC MAGNETIC POWDER AND MANUFACTURING METHOD OF THE SAME, MAGNETIC PAINTING, MAGNETIC POWDER FOR MAGNETIC THERAPY, AND MAGNETIC RECORDING MEDIUM - A metallic magnetic powder where a primary particle of each metallic magnetic particle is a powder without forming an aggregate, and a method of making the same that includes manufacturing a metallic magnetic powder constituted of metallic magnetic particles, containing a metallic magnetic phase, with Fe, or Fe and Co as main components, rare earth elements , or yttrium and one or more non-magnetic components removing the non-magnetic component from the metallic magnetic with a reducing agent, while making a complexing agent exist for forming a complex with the non-magnetic component in water; oxidizing the metallic magnetic particle with the non-magnetic component removed; substituting water adhered to the oxidized metallic magnetic particle with an organic solvent; and | 12-15-2011 |
| 20100132507 | METHOD FOR PATTERNING METAL USING NANOPARTICLE CONTAINING PRECURSORS - Continuous, conducting metal patterns can be formed from metal nanoparticle containing films by exposure to radiation (FIG. | 06-03-2010 |
| 20100056624 | ANIMAL MODEL FOR PERIMENOPAUSE AND MENOPAUSE AND METHODS OF INDUCING OVARIAN FAILURE - The present invention relates to an animal model for human perimenopause and menopause. Also provided by the present invention are methods of making the animal model and methods of screening using the model. Also provided are methods of inducing ovarian failure in animals such as pets and wildlife. | 03-04-2010 |
| 20100034824 | TARGETED BIOCIDES - The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing). The present invention also relates to methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in various diagnostic applications in number of diverse fields such as agriculture, medicine, and national defense. | 02-11-2010 |
| 20080228033 | Optical Coherence Tomography Probe Device - Optical coherence tomograph (OCT) probe device ( | 09-18-2008 |
